🇺🇸 Betaxolol eye drops in United States

11 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 11

Most-reported reactions

1. Sedation — 2 reports (18.18%)
2. Abnormal Loss Of Weight — 1 report (9.09%)
3. Agitation — 1 report (9.09%)
4. Anaemia — 1 report (9.09%)
5. Contraindicated Product Administered — 1 report (9.09%)
6. Contusion — 1 report (9.09%)
7. Decreased Appetite — 1 report (9.09%)
8. Delirium — 1 report (9.09%)
9. Fall — 1 report (9.09%)
10. Myocardial Infarction — 1 report (9.09%)

Source database →

Frequently asked questions

Is Betaxolol eye drops approved in United States?

Betaxolol eye drops does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Betaxolol eye drops in United States?

Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. is the originator. The local marketing authorisation holder may differ — check the official source linked above.